Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1183/13993003.04474-2020 http://scihub22266oqcxt.onion/10.1183/13993003.04474-2020 34016619!8135927!34016619     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34016619&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Eur+Respir+J 2021 ; 58 (6): ? Nephropedia Template TP {{tp|p=34016619|t=2021. Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study |pdf=|usr=}}{{34016619}} gab.com Text Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study JO: Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=34016619 #FOAvip BACKGROUND: Influenza epidemics were initially considered to be a suitable model for the COVID-19 epidemic, but there is a lack of data concerning patients with chronic respiratory diseases (CRDs), who were supposed to be at risk of severe forms of COVID-19. METHODS: This nationwide retrospective cohort study describes patients with prior lung disease hospitalised for COVID-19 (March-April 2020) or influenza (2018-2019 influenza outbreak). We compared the resulting pulmonary complications, need for intensive care and in-hospital mortality depending on respiratory history and virus. RESULTS: In the 89 530 COVID-19 cases, 16.03% had at least one CRD, which was significantly less frequently than in the 45 819 seasonal influenza patients. Patients suffering from chronic respiratory failure, chronic obstructive pulmonary disease, asthma, cystic fibrosis and pulmonary hypertension were under-represented, contrary to those with lung cancer, sleep apnoea, emphysema and interstitial lung diseases. COVID-19 patients with CRDs developed significantly more ventilator-associated pneumonia and pulmonary embolism than influenza patients. They needed intensive care significantly more often and had a higher mortality rate (except for asthma) when compared with patients with COVID-19 but without CRDs or patients with influenza. CONCLUSIONS: Patients with prior respiratory diseases were globally less likely to be hospitalised for COVID-19 than for influenza, but were at higher risk of developing severe COVID-19 and had a higher mortality rate compared with influenza patients and patients without a history of respiratory illness. Twit Text FOAVip Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study ????Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=34016619 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34016619 #FOAvip English Wikipedia <ref>{{Cite pmid|34016619}}</ref> Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study #MMPMID34016619 Beltramo G; Cottenet J; Mariet AS; Georges M; Piroth L; Tubert-Bitter P; Bonniaud P; Quantin C Eur Respir J 2021[Dec]; 58 (6): ? PMID34016619show ga BACKGROUND: Influenza epidemics were initially considered to be a suitable model for the COVID-19 epidemic, but there is a lack of data concerning patients with chronic respiratory diseases (CRDs), who were supposed to be at risk of severe forms of COVID-19. METHODS: This nationwide retrospective cohort study describes patients with prior lung disease hospitalised for COVID-19 (March-April 2020) or influenza (2018-2019 influenza outbreak). We compared the resulting pulmonary complications, need for intensive care and in-hospital mortality depending on respiratory history and virus. RESULTS: In the 89 530 COVID-19 cases, 16.03% had at least one CRD, which was significantly less frequently than in the 45 819 seasonal influenza patients. Patients suffering from chronic respiratory failure, chronic obstructive pulmonary disease, asthma, cystic fibrosis and pulmonary hypertension were under-represented, contrary to those with lung cancer, sleep apnoea, emphysema and interstitial lung diseases. COVID-19 patients with CRDs developed significantly more ventilator-associated pneumonia and pulmonary embolism than influenza patients. They needed intensive care significantly more often and had a higher mortality rate (except for asthma) when compared with patients with COVID-19 but without CRDs or patients with influenza. CONCLUSIONS: Patients with prior respiratory diseases were globally less likely to be hospitalised for COVID-19 than for influenza, but were at higher risk of developing severe COVID-19 and had a higher mortality rate compared with influenza patients and patients without a history of respiratory illness. |*COVID-19[MESH] |*Influenza, Human/complications/epidemiology[MESH] |Hospital Mortality[MESH] |Humans[MESH] |Retrospective Studies[MESH]Chronic respiratory diseases are predictors of severe outcome in COVID(epmc).pdf DeepDyve Pubget Overpricing